{"entity":{"type":"insider","cik":"0001471956","url":"/insider/0001471956","json_url":"/insider/0001471956.json","name":"Pernock David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2013-11-21","last":"2017-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Pernock David","source":"filing","n_filings":12,"first_seen":"2013-11-21","last_seen":"2017-05-19"}],"transactions":[{"id":4540987,"accession":"0001209191-17-033952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033952","line_url":"/filing/0001209191-17-033952#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Officer (Pres. & Chief Comm. Officer)","role_mark":"O","role_mark_label":"Officer (Pres. & Chief Comm. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Comm. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":255.0,"shares_display":"255","price_per_share":79.69,"price_display":"79.69","price_state":"stated","total_value":20320.95,"total_display":"20,320.95","total_whole":"20,321","shares_owned_after":966.0,"shares_owned_after_display":"966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-19","filed_date":"2017-05-19","scope":"insider"},{"id":4709216,"accession":"0001209191-17-032825","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-032825","line_url":"/filing/0001209191-17-032825#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Officer (Pres. & Chief Comm. Officer)","role_mark":"O","role_mark_label":"Officer (Pres. & Chief Comm. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Comm. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":82.24,"price_display":"82.24","price_state":"stated","total_value":16448.0,"total_display":"16,448.00","total_whole":"16,448","shares_owned_after":711.0,"shares_owned_after_display":"711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-16","scope":"insider"},{"id":4738637,"accession":"0001209191-17-022052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-022052","line_url":"/filing/0001209191-17-022052#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Officer (Pres. & Chief Comm. Officer)","role_mark":"O","role_mark_label":"Officer (Pres. & Chief Comm. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Comm. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61.0,"shares_display":"61","price_per_share":83.98,"price_display":"83.98","price_state":"stated","total_value":5122.78,"total_display":"5,122.78","total_whole":"5,123","shares_owned_after":511.0,"shares_owned_after_display":"511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-21","scope":"insider"},{"id":4829594,"accession":"0001209191-17-019959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-019959","line_url":"/filing/0001209191-17-019959#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Officer (Pres. & Chief Comm. Officer)","role_mark":"O","role_mark_label":"Officer (Pres. & Chief Comm. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. & Chief Comm. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":77.8411,"price_display":"77.84","price_state":"stated","total_value":35028.495,"total_display":"35,028.50","total_whole":"35,028","shares_owned_after":450.0,"shares_owned_after_display":"450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-10","scope":"insider"},{"id":2576458,"accession":"0000357097-16-000202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000357097-16-000202","line_url":"/filing/0000357097-16-000202#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.9217,"price_display":"0.92","price_state":"stated","total_value":46085.0,"total_display":"46,085.00","total_whole":"46,085","shares_owned_after":105600.0,"shares_owned_after_display":"105,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-02","filed_date":"2016-12-02","scope":"insider"},{"id":8652492,"accession":"0000357097-15-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000357097-15-000108","line_url":"/filing/0000357097-15-000108#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.999,"price_display":"5.00","price_state":"stated","total_value":14997.0,"total_display":"14,997.00","total_whole":"14,997","shares_owned_after":55600.0,"shares_owned_after_display":"55,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-13","filed_date":"2015-11-13","scope":"insider"},{"id":8195943,"accession":"0000357097-15-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000357097-15-000090","line_url":"/filing/0000357097-15-000090#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":6.54,"price_display":"6.54","price_state":"stated","total_value":22890.0,"total_display":"22,890.00","total_whole":"22,890","shares_owned_after":52600.0,"shares_owned_after_display":"52,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider"},{"id":8284697,"accession":"0001192482-15-000188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-15-000188","line_url":"/filing/0001192482-15-000188","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16600.0,"shares_display":"16,600","price_per_share":4.2980361445783135,"price_display":"4.30","price_state":"stated","total_value":71347.4,"total_display":"71,347.40","total_whole":"71,347","shares_owned_after":49100.0,"shares_owned_after_display":"49,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-13","filed_date":"2015-05-13","scope":"insider","n_lines":2},{"id":6446232,"accession":"0001445305-14-005557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445305-14-005557","line_url":"/filing/0001445305-14-005557#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":32500.0,"shares_owned_after_display":"32,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-15","scope":"insider"},{"id":7087431,"accession":"0001192482-14-000242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-14-000242","line_url":"/filing/0001192482-14-000242#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.5371,"price_display":"2.54","price_state":"stated","total_value":12685.5,"total_display":"12,685.50","total_whole":"12,686","shares_owned_after":27500.0,"shares_owned_after_display":"27,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-21","scope":"insider"},{"id":6871157,"accession":"0001192482-14-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-14-000095","line_url":"/filing/0001192482-14-000095#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.954,"price_display":"2.95","price_state":"stated","total_value":36925.0,"total_display":"36,925.00","total_whole":"36,925","shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-05","filed_date":"2014-06-06","scope":"insider"},{"id":5172255,"accession":"0001181431-13-060141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-060141","line_url":"/filing/0001181431-13-060141#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001471956","owner_name":"Pernock David","owner_display_name":"Pernock David","owner_url":"/insider/0001471956","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":36900.0,"total_display":"36,900.00","total_whole":"36,900","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-21","filed_date":"2013-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Officer (Pres. & Chief Comm. Officer)","n_filings":4,"first_seen":"2017-03-10","last_seen":"2017-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000357097","name":"Fibrocell Science, Inc.","url":"/issuer/0000357097","role":"Director, Officer (Chairman and CEO)","n_filings":8,"first_seen":"2013-11-21","last_seen":"2016-12-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001471956","retrieved_at":"2026-08-25T21:07:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}